Genocea Biosciences, Inc. (OTCPK: GNCA.Q)
Health Care · Biotechnology · US
$0.00
-50.00% today · 0.0% 1Y
Genocea Biosciences, Inc. (OTCPK: GNCA.Q) operates in the Biotechnology industry within the Health Care sector. The company is valued at $59.00.
Over the last twelve months the share price has gained 0.0%, trading between 0.00 and 0.01.
Tweenvest scores Genocea Biosciences, Inc. across four factors: quality 26/100, value 39/100. Its strongest factor is value.
GNCA.Q price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $59.00
- Revenue (TTM)
- $1.91M
- P/E
- —
- EPS
- -0.53
- Dividend yield
- —
- Beta (5Y)
- 38.67
- 52-week high
- $0.01
- 52-week low
- $0.00
- Avg volume (3M)
- —
- Shares outstanding
- 58.78M
- Employees
- —
- Next earnings
- —
Other Biotechnology companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| AbbVie Inc.NYSE: ABBV | $469.68B | $262.90 | -1.09% |
| Amgen Inc.NasdaqGS: AMGN | $239.09B | $440.34 | -0.43% |
| Gilead Sciences, Inc.NasdaqGS: GILD | $184.47B | $148.09 | -0.46% |
| Vertex Pharmaceuticals IncorporatedNasdaqGS: VRTX | $140.13B | $547.29 | -1.01% |
| Regeneron Pharmaceuticals, Inc.NasdaqGS: REGN | $83.24B | $814.79 | -2.25% |
| argenx SEENXTBR: ARGX | $64.17B | €897.60 | +2.09% |
| Moderna, Inc.NasdaqGS: MRNA | $63.41B | $149.66 | -5.77% |
| CSL LimitedASX: CSL | $59.49B | AU$173.64 | +2.68% |
Figures last refreshed Aug 18, 2026.